NewAmsterdam Pharma Company NV Ordinary Shares

Price & Volume

Stats

See more
52W Range
$14.06-$37.07
Market Cap
$3.7B
Shares Short
7M

Financials

See more
Revenue (12 Mos)
$64M
Revenue Growth (YoY)
740.1%
Gross Profit (12 Mos)
$64M
Diluted EPS
-$1.60

About

CEO
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Address
Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
68